BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 34789253)

  • 1. Analysis of the potential for a malaria vaccine to reduce gaps in malaria intervention coverage.
    Unwin HJT; Mwandigha L; Winskill P; Ghani AC; Hogan AB
    Malar J; 2021 Nov; 20(1):438. PubMed ID: 34789253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential public health impact of RTS,S malaria candidate vaccine in sub-Saharan Africa: a modelling study.
    Sauboin CJ; Van Bellinghen LA; Van De Velde N; Van Vlaenderen I
    Malar J; 2015 Dec; 14():524. PubMed ID: 26702637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimated impact of RTS,S/AS01 malaria vaccine allocation strategies in sub-Saharan Africa: A modelling study.
    Hogan AB; Winskill P; Ghani AC
    PLoS Med; 2020 Nov; 17(11):e1003377. PubMed ID: 33253211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age and gender trends in insecticide-treated net use in sub-Saharan Africa: a multi-country analysis.
    Olapeju B; Choiriyyah I; Lynch M; Acosta A; Blaufuss S; Filemyr E; Harig H; Monroe A; Selby RA; Kilian A; Koenker H
    Malar J; 2018 Nov; 17(1):423. PubMed ID: 30428916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spatiotemporal analysis of insecticide-treated net use for children under 5 in relation to socioeconomic gradients in Central and East Africa.
    Kim H; Miller FD; Hernandez A; Tanser F; Mogeni P; Cuadros DF
    Malar J; 2020 Apr; 19(1):163. PubMed ID: 32321547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design of a phase III multicenter trial to evaluate the efficacy of the RTS,S/AS01 malaria vaccine in children across diverse transmission settings in Africa.
    Leach A; Vekemans J; Lievens M; Ofori-Anyinam O; Cahill C; Owusu-Agyei S; Abdulla S; Macete E; Njuguna P; Savarese B; Loucq C; Ballou WR;
    Malar J; 2011 Aug; 10():224. PubMed ID: 21816029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modelling the relative cost-effectiveness of the RTS,S/AS01 malaria vaccine compared to investment in vector control or chemoprophylaxis.
    Topazian HM; Schmit N; Gerard-Ursin I; Charles GD; Thompson H; Ghani AC; Winskill P
    Vaccine; 2023 May; 41(20):3215-3223. PubMed ID: 37080831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population coverage of artemisinin-based combination treatment in children younger than 5 years with fever and Plasmodium falciparum infection in Africa, 2003-2015: a modelling study using data from national surveys.
    Bennett A; Bisanzio D; Yukich JO; Mappin B; Fergus CA; Lynch M; Cibulskis RE; Bhatt S; Weiss DJ; Cameron E; Gething PW; Eisele TP
    Lancet Glob Health; 2017 Apr; 5(4):e418-e427. PubMed ID: 28288746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-uptake of childhood vaccination among the children of HIV-infected mothers in sub-Saharan Africa: A multilevel analysis.
    Adetokunboh OO; Uthman OA; Wiysonge CS
    Hum Vaccin Immunother; 2018; 14(10):2405-2413. PubMed ID: 30036129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing whether universal coverage with insecticide-treated nets has been achieved: is the right indicator being used?
    Koenker H; Arnold F; Ba F; Cisse M; Diouf L; Eckert E; Erskine M; Florey L; Fotheringham M; Gerberg L; Lengeler C; Lynch M; Mnzava A; Nasr S; Ndiop M; Poyer S; Renshaw M; Shargie E; Taylor C; Thwing J; Van Hulle S; Ye Y; Yukich J; Kilian A
    Malar J; 2018 Oct; 17(1):355. PubMed ID: 30305127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A subnational profiling analysis reveals regional differences as the main predictor of ITN ownership and use in Nigeria.
    Andrada A; Herrera S; Inyang U; Mohammed AB; Uhomoibhi P; Yé Y
    Malar J; 2019 May; 18(1):185. PubMed ID: 31138216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimating the number of insecticide-treated nets required by African households to reach continent-wide malaria coverage targets.
    Miller JM; Korenromp EL; Nahlen BL; W Steketee R
    JAMA; 2007 May; 297(20):2241-50. PubMed ID: 17519414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Policy uptake and implementation of the RTS,S/AS01 malaria vaccine in sub-Saharan African countries: status 2 years following the WHO recommendation.
    Osoro CB; Ochodo E; Kwambai TK; Otieno JA; Were L; Sagam CK; Owino EJ; Kariuki S; Ter Kuile FO; Hill J
    BMJ Glob Health; 2024 Apr; 9(4):. PubMed ID: 38688566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimating global and regional disruptions to routine childhood vaccine coverage during the COVID-19 pandemic in 2020: a modelling study.
    Causey K; Fullman N; Sorensen RJD; Galles NC; Zheng P; Aravkin A; Danovaro-Holliday MC; Martinez-Piedra R; Sodha SV; Velandia-González MP; Gacic-Dobo M; Castro E; He J; Schipp M; Deen A; Hay SI; Lim SS; Mosser JF
    Lancet; 2021 Aug; 398(10299):522-534. PubMed ID: 34273292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of maternal HIV status on vaccination coverage among sub-Saharan African children: A socio-ecological analysis.
    Adetokunboh OO; Uthman OA; Wiysonge CS
    Hum Vaccin Immunother; 2018; 14(10):2373-2381. PubMed ID: 29718769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimated impact on birth weight of scaling up intermittent preventive treatment of malaria in pregnancy given sulphadoxine-pyrimethamine resistance in Africa: A mathematical model.
    Walker PG; Floyd J; Ter Kuile F; Cairns M
    PLoS Med; 2017 Feb; 14(2):e1002243. PubMed ID: 28245259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Public health impact and cost-effectiveness of the RTS,S/AS01 malaria vaccine: a systematic comparison of predictions from four mathematical models.
    Penny MA; Verity R; Bever CA; Sauboin C; Galactionova K; Flasche S; White MT; Wenger EA; Van de Velde N; Pemberton-Ross P; Griffin JT; Smith TA; Eckhoff PA; Muhib F; Jit M; Ghani AC
    Lancet; 2016 Jan; 387(10016):367-375. PubMed ID: 26549466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Country specific predictions of the cost-effectiveness of malaria vaccine RTS,S/AS01 in endemic Africa.
    Galactionova K; Tediosi F; Camponovo F; Smith TA; Gething PW; Penny MA
    Vaccine; 2017 Jan; 35(1):53-60. PubMed ID: 27890400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune response to the hepatitis B antigen in the RTS,S/AS01 malaria vaccine, and co-administration with pneumococcal conjugate and rotavirus vaccines in African children: A randomized controlled trial.
    Valéa I; Adjei S; Usuf E; Traore O; Ansong D; Tinto H; Owusu Boateng H; Leach A; Mwinessobaonfou Some A; Buabeng P; Vekemans J; Nana LA; Kotey A; Vandoolaeghe P; Ouedraogo F; Sambian D; Lievens M; Tahita MC; Rettig T; Jongert E; Lompo P; Idriss A; Borys D; Ouedraogo S; Prempeh F; Habib MA; Schuerman L; Sorgho H; Agbenyega T
    Hum Vaccin Immunother; 2018 Jun; 14(6):1489-1500. PubMed ID: 29630438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determinants of use of insecticide treated bednets among caregivers of under five children in an urban local government area of Osun state, South-Western Nigeria.
    Esimai OA; Aluko OO
    Glob J Health Sci; 2014 Sep; 7(2):20-7. PubMed ID: 25716380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.